Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso

Descrição

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Viral speciation through subcellular genetic isolation and virogenesis incompatibility
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A cytoskeletal vortex drives phage nucleus rotation during jumbo phage replication in E. coli - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Cytoskeletal Vortex Drives Phage Nucleus Rotation During Jumbo Phage Replication in E. coli
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A cytoskeletal vortex drives phage nucleus rotation during jumbo phage replication in E. coli - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Intracellular Organization by Jumbo Bacteriophages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Genomic characterization of four novel bacteriophages infecting the clinical pathogen Klebsiella pneumoniae
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Viruses, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Jumbo Phage Forms a Nucleus-like Compartment to Evade Bacterial Defense Systems
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
de por adulto (o preço varia de acordo com o tamanho do grupo)